发明名称 METHOD OF INHIBITING MUTANT C-KIT
摘要 The present invention includes a method of reducing or inhibiting the kinase activity of C-KIT mutant tyrosine kinase activity in a cell or a subject, and the use of such compound for treating mutant C-KIT driven cell proliferative disorder(s) in a subject related to using a compound of the present invention:;;or pharmaceutically acceptable salt thereof.
申请公布号 US2016367545(A1) 申请公布日期 2016.12.22
申请号 US201615255912 申请日期 2016.09.02
申请人 Arog Pharmaceuticals, LLC 发明人 Jain Vinay K.
分类号 A61K31/4709 主分类号 A61K31/4709
代理机构 代理人
主权项 1. A method of inhibiting or reducing mutant C-KIT tyrosine kinase activity or expression in a subject suffering from a proliferative disease which comprises administering to the subject having or suspected to have the proliferative disease, a therapeutically effective amount of the compound of Formula I:or a pharmaceutically acceptable salt or solvate thereof.
地址 Dallas TX US